Oxygen sensing, homeostasis, and disease [7]

New England Journal of Medicine

Volumn 365, Issue 19, 2011, Pages 1845-1846

  De Bels, David ^a   Corazza, Francis ^a   Balestra, Costantino ^b  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b Haute Ecole Bruxelles Brabant   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

CANCER CELL; CANCER SURVIVAL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HYPEROXIA; HYPOXIA; LETTER; METASTASIS; OXYGEN SENSING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL; ANIMAL; ANOXIA; CARDIOVASCULAR DISEASE; METABOLISM; NEOPLASM; NOTE; PHYSIOLOGY; PULMONARY HYPERTENSION; CELL PH; ISCHEMIA; PROTEIN FUNCTION; SENSOR;

ANIMALS; ANOXIA; CARDIOVASCULAR DISEASES; HOMEOSTASIS; HUMANS; HYPERTENSION, PULMONARY; HYPOXIA-INDUCIBLE FACTOR 1; NEOPLASMS;

EID: 80955123535     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1110602     Document Type: Letter

References (3)

1. Semenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med 2011;365:537-47. [Erratum, N Engl J Med 2011; 365:968.]
2. Balestra C, Germonpré P, Poortmans JR, Marroni A. Serum erythropoietin levels in healthy humans after a short period of normobaric and hyperbaric oxygen breathing: the "normobaric oxygen paradox." J Appl Physiol 2006;100:512-8. (Pubitemid 43671602)
3. De Bels D, Corazza F, Germonpré P, Balestra C. The normobaric oxygen paradox: a novel way to administer oxygen as an adjuvant treatment for cancer? Med Hypotheses 2011;76:467-70.